SCHEMBL7539631

SCHEMBL7539631

O=C(O)c1ccc(C(=O)Oc2ccccc2Cl)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.64
RXRA P19793 1/20 0.64
RXRB P28702 1/20 0.64
KMT2A Q03164 6/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
MAPT P10636 3/20 0.53
PTK2B Q14289 1/20 0.50
MEN1 O00255 4/20 0.49
LMNA P02545 2/20 0.49
ALDH1A1 P00352 1/20 0.49
NPC1 O15118 2/20 0.49
TP53 P04637 2/20 0.49
RAB9A P51151 2/20 0.49
NR1I2 O75469 1/20 0.49
AHR P35869 1/20 0.49
TAAR1 Q96RJ0 1/20 0.49
LPAR1 Q92633 4/20 0.48
LPAR5 Q9H1C0 4/20 0.48
MITF O75030 1/20 0.48
XBP1 P17861 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5706002 0.91 KMT2A (0.63) HPGDRXRARXRBKMT2ASMN1; SMN2
SCHEMBL3149726 0.87 PTK2B (0.51) HPGDRXRARXRBKMT2ASMN1; SMN2
SCHEMBL10782892 0.87 MAPT (0.62) HPGDRXRARXRBKMT2ASMN1; SMN2
SCHEMBL10604770 0.86 HPGD (0.53) HPGDRXRARXRBKMT2ASMN1; SMN2
SCHEMBL1975083 0.86 HPGD (0.51) HPGDRXRARXRBKMT2ASMN1; SMN2
SCHEMBL5706048 0.84 SLC6A3 (0.58) KMT2ASMN1; SMN2MAPTPTK2BLMNA
SCHEMBL5706143 0.84 ESR1 (0.56) KMT2ASMN1; SMN2MAPTPTK2BMEN1
SCHEMBL5706248 0.83 HPGD (0.53) HPGDRXRARXRBKMT2ASMN1; SMN2
SCHEMBL5706251 0.81 L3MBTL1 (0.58) KMT2ASMN1; SMN2MAPTALDH1A1NPC1
SCHEMBL7542216 0.81 ALDH1A1 (0.50) HPGDRXRARXRBKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 HPGD 3530/4885RXRA 2680/4885RXRB 2055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.